Cell Cryopreservation

Global Cell Cryopreservation Market to Reach US$31.4 Billion by 2030

The global market for Cell Cryopreservation estimated at US$10.8 Billion in the year 2024, is expected to reach US$31.4 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cell Cryopreservation Consumables, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach US$19.1 Billion by the end of the analysis period. Growth in the Cell Freezing Media segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 26.6% CAGR

The Cell Cryopreservation market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.5 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Cell Cryopreservation Market – Key Trends & Drivers Summarized

Why Is the Demand for Cell Cryopreservation Increasing?

The demand for cell cryopreservation is increasing due to the rapid growth of regenerative medicine, biopharmaceutical research, and cell-based therapies. Cryopreservation is a critical process in storing biological materials such as stem cells, immune cells, reproductive cells, and genetically modified cells for long-term use in research and clinical applications. With the rising adoption of personalized medicine and advancements in stem cell therapy, the need for reliable cryopreservation techniques has become essential for ensuring cell viability and functionality.

Additionally, the increasing number of clinical trials focused on regenerative treatments, immunotherapies, and gene-editing technologies has further driven the need for high-quality cryopreservation solutions. Hospitals, research institutions, and biotechnology companies rely on cryopreservation to store and transport viable cells for use in future medical applications. As demand grows for cell-based treatments in oncology, neurology, and reproductive health, the cell cryopreservation market is poised for continued expansion.

How Are Technological Advancements Improving Cell Cryopreservation?

Innovations in cryoprotectant formulations, automated freezing systems, and cryogenic storage solutions are enhancing the efficiency and reliability of cell cryopreservation. One of the most significant advancements is the development of vitrification techniques, which prevent ice crystal formation and improve the survival rates of cryopreserved cells. Unlike traditional slow-freezing methods, vitrification allows for ultra-rapid freezing, preserving cellular integrity and reducing the risk of cryo-injury.

Another major breakthrough is the use of AI-driven monitoring systems and automated liquid nitrogen storage facilities. These technologies ensure optimal temperature control, minimize sample degradation, and provide real-time tracking of stored cells. Additionally, advancements in cryoprotective agents are reducing toxicity risks while improving post-thaw cell recovery. The integration of blockchain for data security and traceability in biobanking is also gaining traction, enhancing transparency and compliance in cryopreservation processes. With continuous improvements in freezing protocols and storage infrastructure, cell cryopreservation is becoming more efficient, scalable, and accessible across multiple medical and research fields.

Which Market Trends Are Driving Growth in the Cell Cryopreservation Industry?

The increasing demand for stem cell banking and regenerative medicine is one of the most influential trends shaping the cell cryopreservation market. Stem cell therapies for conditions such as spinal cord injuries, autoimmune disorders, and heart disease require long-term storage of viable cells, driving investments in cryopreservation technologies. Additionally, fertility preservation has emerged as a major growth area, with more individuals opting to freeze eggs, sperm, and embryos for future reproductive use.

Another key trend influencing market growth is the expansion of biobanking initiatives. Governments and research institutions are investing in large-scale biorepositories to support genomic research, drug discovery, and personalized medicine. The rise of decentralized cryopreservation services, which enable remote collection and storage of biological samples, is also gaining traction. Additionally, regulatory advancements in biobanking and cell therapy manufacturing are shaping the industry, ensuring compliance with Good Manufacturing Practices and ethical guidelines. As the need for cell preservation grows across various sectors, the market is expected to experience significant expansion in the coming years.

What Are the Key Growth Drivers Shaping the Future of the Cell Cryopreservation Market?

The growth in the cell cryopreservation market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in cell-based therapies, and expanding applications in reproductive health. One of the primary growth drivers is the rising number of clinical trials for cellular immunotherapies, such as CAR-T cell therapy for cancer treatment. These therapies require stable and viable cell storage, making cryopreservation an essential component of advanced treatment protocols.

Another crucial driver shaping the market is the increasing awareness and adoption of fertility preservation services. With delayed parenthood becoming more common, demand for cryopreserved reproductive cells has surged, leading to the expansion of fertility clinics and biobanks worldwide. Additionally, government support for stem cell research and regenerative medicine initiatives is fueling investments in cryopreservation infrastructure. As new therapeutic applications continue to emerge, the need for reliable, high-quality cell cryopreservation solutions will remain strong, positioning the market for sustained growth in the years ahead.

SCOPE OF STUDY:

The report analyzes the Cell Cryopreservation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Cell Cryopreservation Consumables, Cell Freezing Media, Cell Cryopreservation Equipment); Application (Stem Cells Application, Oocytes and Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application, Other Applications); End-Use (IVF Clinics End-Use, Biopharmaceutical and Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Avantor Inc.
• Biocision, LLC
• BioLife Solutions Inc.
• Cardinal Health, Inc.
• Cesca Therapeutics Inc.
• Chart Industries, Inc.
• Corning Incorporated
• Creative Biolabs
• CryoLife, Inc.
• Custom Biogenic Systems
• Danaher Corporation
• GE Healthcare
• Helmer Scientific
• HiMedia Laboratories
• Lonza Group Ltd.
• Merck KGaA
• Organ Recovery Systems Inc.
• PromoCell GmbH
• Sartorius AG
• Sigma-Aldrich Co. LLC

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.